[
  {
    "vignette_index": 477,
    "input": "Acute Conjunctivitis or Ocular Trauma END",
    "output": "THINKING: The patient presents with eye symptoms such as redness, swelling, and tearing following playing soccer, with a confirmed final diagnosis of Type II leprosy reaction. Given the context, this is likely a leprosy-associated ocular complication rather than typical conjunctivitis or trauma. Leprosy reactions, particularly Type II (erythema nodosum leprosum), can involve ocular tissues with presentations like conjunctivitis, iridocyclitis, or other inflammatory responses. The recent activity and symptoms suggest inflammatory ocular involvement necessitating prompt management to prevent vision loss.  STEP 1 - DIAGNOSIS CONFIRMATION & SEVERITY ASSESSMENT: - Primary diagnosis confidence: High, based on the context of leprosy and recent ocular symptoms. - Severity classification: Moderate to severe, as symptoms involve redness, swelling, tearing, and potential inflammation risking eye damage. - Urgency level: Urgent care needed now to assess for possible inflammation or ocular involvement associated with leprosy reaction. - Differential considerations still requiring monitoring: Traumatic injury, conjunctivitis, uveitis, or other infectious or inflammatory ocular conditions.  STEP 2 - EVIDENCE-BASED TREATMENT SELECTION: - First-line treatment per guidelines: Systemic corticosteroids to control inflammation caused by Type II leprosy reactions. - Supporting evidence: Corticosteroids are the mainstay for managing severe inflammatory reactions in leprosy, preventing complications such as corneal involvement or vision loss. - Patient-specific considerations: Consider potential side effects, immune status, and need for coordination with leprosy treatment. - Contraindications or cautions: Watch for steroid side effects, monitor blood sugar, blood pressure, and signs of secondary infection.  STEP 3 - PHARMACOLOGICAL INTERVENTIONS: - Primary medication choice: Prednisone 40 mg daily, titrated based on response. - Rationale for selection: Effective anti-inflammatory with rapid onset, suitable for managing ocular inflammation. - Expected timeline for improvement: Symptoms often improve within 48-72 hours; full resolution may take 1-2 weeks. - Key side effects to monitor: Hyperglycemia, hypertension, gastrointestinal symptoms, mood changes, infections. - Alternative medications if first-line fails: Thalidomide (used in refractory cases), or adjunctive immunosuppressants under specialist guidance.  STEP 4 - NON-PHARMACOLOGICAL INTERVENTIONS: - Primary non-drug interventions: Eye protection, avoid rubbing eyes, ensure adequate hydration. - Patient education priorities: Importance of medication adherence, recognition of worsening symptoms. - Lifestyle modifications: Maintain good eye hygiene, avoid irritants, and regular sleep. - Behavioral interventions: Stress management, reinforce importance of routine follow-up.  STEP 5 - MONITORING & FOLLOW-UP STRATEGY: - Follow-up timeline: Re-evaluate in 3-5 days or sooner if symptoms worsen. - Monitoring parameters: Symptom progression, visual acuity, ocular examination findings. - Red flag symptoms: Sudden vision loss, severe pain, increasing redness, new floaters or flashes. - Treatment response assessment: Symptom resolution, decreased ocular redness/swelling, improved tearing.  STEP 6 - PATIENT COMMUNICATION STRATEGY: - Communication approach: Use clear, simple language, allowing space for tangential storytelling while gently guiding focus on key points. - Addressing patient concerns: Reassure about the safety and importance of treatment, address worries about medication side effects. - Adherence strategies: Emphasize importance of medication schedule, set reminders. - Family involvement: Encourage family to support medication adherence and attend follow-up visits.  STEP 7 - COORDINATION & REFERRALS: - Specialist referrals needed: Ophthalmologist for detailed ocular assessment and management within 24-48 hours. - Other healthcare team members: Infectious disease or dermatology consult for leprosy management. - Community resources: Leprosy support groups, patient education materials. - Insurance/cost considerations: Assist patient in understanding medication costs and insurance coverage; consider assistance programs if needed.\nANSWER: Based on the diagnosis of Type II leprosy reaction with ocular involvement, I recommend a comprehensive treatment approach that combines evidence-based medical management with patient-centered care strategies. The treatment plan includes initiating systemic corticosteroids (e.g., Prednisone 40 mg daily) to rapidly control inflammation, with close monitoring for side effects. Immediate management focuses on reducing ocular inflammation to prevent complications like visual impairment. Long-term management involves ongoing coordination with an ophthalmologist and leprosy specialist, ensuring regular follow-up to monitor symptom resolution and prevent recurrence. Patient education emphasizes medication adherence, recognition of warning signs, and eye protection. Follow-up should occur within 3-5 days, with prompt action if symptoms worsen. This integrated approach aims to stabilize ocular symptoms, prevent permanent damage, and support the patient\u2019s overall health and understanding of their condition.",
    "gold_diagnosis": "Type II leprosy reaction"
  }
]